These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2525784)

  • 1. Influence of propranolol on platelet aggregation and thromboxane B2 production from platelet-rich plasma and whole blood.
    Anfossi G; Trovati M; Mularoni E; Massucco P; Calcamuggi G; Emanuelli G
    Prostaglandins Leukot Essent Fatty Acids; 1989 Apr; 36(1):1-7. PubMed ID: 2525784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of diltiazem on thromboxane B2 production from platelet-rich plasma and whole blood.
    Anfossi G; Trovati M; Mularoni E; Massucco P; Cavalot F; Mattiello L; Emanuelli G
    Prostaglandins Leukot Essent Fatty Acids; 1991 Nov; 44(3):149-54. PubMed ID: 1808624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenothiazine compounds enhance phentolamine effects on platelet aggregation and thromboxane B2 production.
    Anfossi G; Trovati M; Mularoni E; Massucco P; Cavalot F; Mattiello L; Emanuelli G
    Arch Int Pharmacodyn Ther; 1990; 307():142-61. PubMed ID: 1982777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of propranolol therapy on platelet release and prostaglandin generation in patients with coronary heart disease.
    Mehta J; Mehta P
    Circulation; 1982 Dec; 66(6):1294-9. PubMed ID: 6216027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
    Cattaneo M; Tenconi PM; Lecchi A; Mannucci PM
    Thromb Res; 1991 Jun; 62(6):717-24. PubMed ID: 1926062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers.
    Gasser JA; Betterridge DJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S29-34. PubMed ID: 1721976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion.
    Hornby EJ; Foster MR; McCabe PJ; Stratton LE
    Thromb Haemost; 1989 Jun; 61(3):429-36. PubMed ID: 2529661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of propranolol in vitro and in vivo on platelet function and thromboxane formation in normal volunteers.
    Siess W; Lorenz R; Roth P; Weber PC
    Agents Actions; 1983 Feb; 13(1):29-34. PubMed ID: 6344593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation.
    Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
    Thromb Haemost; 1985 Aug; 54(2):480-4. PubMed ID: 2867620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the influence of the interaction between acetylsalicylic acid and salicylic acid on platelet function in whole blood and isolated platelets: influence of neutrophils.
    González-Correa JA; Muñoz-Marín J; López-Villodres JA; Navas MD; Guerrero A; Torres JA; De La Cruz JP
    Pharmacol Res; 2007 Aug; 56(2):168-74. PubMed ID: 17644353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro.
    Bode-Böger SM; Böger RH; Galland A; Frölich JC
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):143-50. PubMed ID: 9521487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine.
    Stuart MJ; Dusse J; Clark DA; Walenga RW
    Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. At low extracellular calcium concentration platelet activating factor induces beta-thromboglobulin release from human platelets through thromboxane-endoperoxides formation.
    Zatta A; Zanetti A; Dejana E; Prosdocimi M
    Agents Actions; 1987 Oct; 22(1-2):151-8. PubMed ID: 2961218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
    Gross PL; Rand ML; Barrow DV; Packham MA
    Atherosclerosis; 1991 May; 88(1):77-86. PubMed ID: 1878012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
    Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human platelet aggregation and thromboxane B2 production by melatonin. Correlation with plasma melatonin levels.
    Vacas MI; Del Zar MM; Martinuzzo M; Falcon C; Carreras LO; Cardinali DP
    J Pineal Res; 1991; 11(3-4):135-9. PubMed ID: 1795222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet aggregation, platelet cAMP levels and thromboxane B2 synthesis in patients with diabetes mellitus.
    Chen SY; Yu BJ; Liang YQ; Lin WD
    Chin Med J (Engl); 1990 Apr; 103(4):312-8. PubMed ID: 2167823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil.
    Petroni A; Blasevich M; Salami M; Papini N; Montedoro GF; Galli C
    Thromb Res; 1995 Apr; 78(2):151-60. PubMed ID: 7482432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.